- Q1 2024 Icade SA Earnings Call TranscriptApr 22, 2024€24.8 (+2.73%)Earnings
- Q3 2023 Icade SA Earnings Call TranscriptOct 23, 2023€28.36 (-1.32%)Earnings
- Half Year 2023 Icade SA Earnings Call TranscriptJul 24, 2023€37.26 (+0.05%)Earnings
- Q1 2023 Icade SA Earnings Call TranscriptApr 24, 2023Earnings
- Icade SA Corporate Call TranscriptMar 14, 2023
- Full Year 2022 Icade SA Earnings Call TranscriptFeb 20, 2023€45 (+2.79%)Earnings
- Icade SA Investor Day 2022 TranscriptNov 28, 2022
- Q3 2022 Icade SA Earnings Call TranscriptOct 24, 2022€36.4 (+1.85%)Earnings
- Half Year 2022 Icade SA Earnings Call TranscriptJul 25, 2022€46.46 (+0.04%)Earnings
- Q1 2022 Icade SA Corporate Sales Call TranscriptApr 25, 2022
- Full Year 2021 Icade SA Earnings Call TranscriptFeb 21, 2022€58.05 (-3.65%)Earnings
- Icade SA Investor Day TranscriptNov 29, 2021
- Q3 2021 Icade SA Corporate Sales Call TranscriptOct 25, 2021
- Half Year 2021 Icade SA Earnings Call TranscriptJul 26, 2021€75.5 (-0.07%)Earnings
- Q1 2021 Icade SA Corporate Sales Call TranscriptApr 26, 2021
- Full Year 2020 Icade SA Earnings Presentation TranscriptFeb 22, 2021
- Icade SA Investor Day TranscriptNov 23, 2020
- Q3 2020 Icade SA Corporate Sales Call TranscriptOct 22, 2020
- Half Year 2020 Icade SA Earnings Call TranscriptJul 21, 2020€58.5 (+1.56%)Earnings
- Full Year 2019 Icade SA Earnings Call TranscriptFeb 17, 2020€102.6 (-1.25%)Earnings
- Icade SA Investor Day TranscriptNov 25, 2019
- Half Year 2019 Icade SA Earnings Call TranscriptJul 22, 2019€76.9 (-3.27%)Earnings
- Full Year 2018 Icade SA Earnings Call (English, French) TranscriptFeb 18, 2019Earnings
Half Year 2023 Icade SA Earnings Call Transcript
Good morning everyone. I am Nicolas Joly. I'm here with Victoire Aubry, our CFO. It's a real pleasure for me to be here today. We have several subjects on the agenda. We will start by giving you an update on the disposal of Icade Sante, we will then follow with our half year performance and financial results before I give you my first perspective after the first 100 days and we will conclude with our outlook for the year. But let's start our presentation with Slide 5. When I joined as new CEO of Icade, I had 3 priorities. First one was to deliver Icade Sante's Stage 1 disposal. The second is to perform a complete deep dive on our portfolio and assess the situation. And the third will be to leverage that assessment to design the future trajectory of the group. So let me now lead you through the key takeaways of the period that I'd like to share with you.
Unsurprisingly, we want to discuss first the latest updates on the sale of Icade Sante. The key new piece of information is that as planned, Stage 1 is completed as of July 5, date by which we sold 63% of our stake in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)